Dr Jennifer Gill is an Associate Director at the (MTRG) at the London School of Economics and Political Science. She has a BSc in Pharmacology from The University of Aberdeen and a PhD in Genetics from The University of Edinburgh.
Before joining ÐÓ°ÉÂÛ̳, Jennifer worked as a Senior Postdoctoral Research Associate in the Research Department of Pharmacy Practice and Policy at University College London, acting as an academic consultant for a number of large, multinational companies. Working on the border of academia and consultancy has given Jennifer a unique insight into project management, health communication and knowledge transfer in numerous areas of public health and pharmacy policy, including issues around population ageing, the burden of chronic pain, the future of cancer treatment, MS and medicines access.
At ÐÓ°ÉÂÛ̳, Jennifer has worked with a number of pharmaceutical companies to analyse the use of real world evidence in decision-making across Europe, determine levels of implementation and resulting impact of external reference pricing within and across borders and develop the largest global survey of those with hepatocellular carcinoma in order to better understand the patient journey.
Expertise: pharmacology; genetics; project management; health communication; knowledge transfer; public health; pharmacy policy; chronic pain; population ageing; cancer; MS
ÐÓ°ÉÂÛ̳ Consulting projects:
-
Sustainable Healthcare Financing for SDG3 in ASEAN-6
March 2024
Client: US-ASEAN Business Council
Authors: Jennifer Gill, Danitza Chavez, Caitlin Main, Aurelio Miracolo and Panos Kanavos
-
Determining the Benefits of Improving Secondary Prevention of Cardiovascular Disease
November 2023
Client: EFPIA Cardiovascular Health Platform
Authors: Jennifer Gill, Aurelio Miracolo, Konstantina Politopoulou, Sahan Jayawardana, Efstratios Apostolou, Alex Carter and Panos Kanavos
-
Towards Better Outcomes in Autism by Addressing Policy Change
October 2022
Client: F. Hoffmann La Roche
Authors: Olina Efthymiadou, Bregtje Kamphuis, Jennifer Gill, Madeleine Haig and Panos Kanavos
- Access to medicines in Europe: Delays and challenges for timely patient access
November 2021
Client: MSD
Team: Bregtje Kamphuis, Anna-Maria Fontrier, Olina Efthymiadou, Jennifer Gill, Hana Salyga and Panos Kanavos
- The Role of Virtual Health Care and the Pharmaceutical Sector in Improving Population Health
June 2021
Client: Sanofi
Team: Panos Kanavos, Bregtje Kamphuis, Jennifer Gill, Michelle Vogelzang, Madeleine Haig, Vasiliki Kolovou & Anna-Maria Frontrier
-
Access to Personalised Oncology in Europe
November 2020
Client: European Federation of Pharmaceutical Industries and Associations (EFPIA)
Authors: Jennifer Gill, Anna-Maria Fontrier, Aurelio Miracolo & Panos Kanavos
-
Latin America Healthcare System Overview: A comparative analysis of fiscal space in healthcare
August 2019
Client: F. Hoffmann-La Roche AG
Authors: , Georgia Colville Parkin, Bregtje Kamphuis & Jennifer Gill
-
European survey on the use of Real World Evidence
January 2017 - May 2018
Client: F. Hoffmann - La Roche
Team members: Jennifer Gill & Panos Kanavos
-
The use of Real World Evidence – Opportunities for Europe
November 2016 - January 2018
Client: F. Hoffmann - La Roche
Team members: Jennifer Gill, Bregtje Kamphuis & Panos Kanavos
Multiple project outputs
-
External Reference Pricing within and across countries
January 2016 - November 2017
Client: Pfizer
Team members: Panos Kanavos, Jennifer Gill, Anna-Maria Fontrier & Olina Efthymiadou
Multiple project outputs
-
Improving Access to Contraception
September 2017
Client: Pfizer
Authors: Jennifer Gill & David Taylor
-
Understanding the Hepatocellular Carcinoma (HCC) Patient Landscape: Results of the first global survey of people living with HCC
January 2017 – November 2017
Client: Sirtex Medical
Authors:Panos Kanavos, Jennifer Gill, Andrei Baiceanu, Paul Clark, Andrew Langford, Bee Abdul Latiff Julianah, Andrea Wilson, Pei-Ming Yang & Eric Yoshida